Find Information on a:
View all Postings for:
Search ClotCare
|
Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP
Director
Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP is Clinical Professor of Pharmacy at the University of Washington School of Pharmacy and Director of Anticoagulation Services at the University of Washington Medical Center. As a clinician and educator in the field of antithrombotic pharmacotherapy, she has contributed extensively to the care of patients and the education of health care providers about antithrombotic pharmacotherapy. She is the author of numerous scientific papers and book chapters, and co-editor of Managing Oral Anticoagulation Therapy: Clinical and Operational Guidelines. She lectures frequently, maintains an active clinical research program, and is board-certified as an anticoagulation care provider. The Anticoagulation Services program at the University of Washington Medical Center, which Dr. Wittkowsky directs, has served as a training site and model for pharmacist-managed anticoagulation clinics throughout the US and Canada. Dr. Wittkowsky serves as an editorial board member and reviewer for several scientific journals, and on the board of directors for the The Anticoagulation Forum, a multidisciplinary organization of anticoagulation care providers. She is the director of the Northwest Anticoagulation Consortium and a preceptor for the ASHP Research and Education Foundation's Anticoagulation Service Traineeship, and a member of the American College of Chest Physicians 8th Conference on Antithrombotic and Thrombolytic Therapy
Dr. Wittkowsky currently services as a consultant to Boehringer-Ingelheim (dabigatran) and in the past has served as a consultant to Bristol Myers Squibb (warfarin), Sanofi Syntholabo (fondaparinux, idraparinux), AztraZeneca (ximelagatran), SmithKline Beeacham (argatroban), Berlex (lepirudin), Aventis (enoxaparin), and The Medicines Company (bivalirudin).
Editorial Board Members
-
Henry I. Bussey, Pharm.D., FCCP, FAHA -- San Antonio, TX
-
Marie B. Walker, BBA -- Fresno, CA & San Antonio, TX
-
Mary Amato, Pharm.D., MPH -- Boston, MA
-
Jack E. Ansell, M.D. -- Boston, MA
-
William E. Dager, Pharm.D., FCSHP -- Sacramento, CA
-
Susan C. Fagan, Pharm.D., BCPS, FCCP -- Augusta, GA
-
Samuel Z. Goldhaber, M.D. -- Boston, MA
-
James B. Groce III, Pharm.D., CACP -- Greensboro, NC
-
Stuart T. Haines, Pharm.D., FCCP, FASHP, FAPhA -- W. Palm Beach, FL
-
David W. Hawkins, Pharm.D. -- Sacramento, CA
-
Elaine M. Hylek, MD, MPH -- Boston, MA
-
Roger M. Lyons, MD, FACP -- San Antonio, TX
-
Ruth Morrison, R.N., B.S.N., C.V.N. -- Boston, MA
-
Edith A. Nutescu, Pharm.D. -- Chicago, IL
-
Sarah A. Spinler, PharmD, FCCP, BCPS (AQ Cardiology) -- Philadelphia, PA
-
Alex C. Spyropoulos, MD, FACP, FCCP -- Albuquerque, NM
-
Victor F. Tapson, M.D. -- Durham, NC
-
Alexander G.G. Turpie, MD, FRCP, FACP, FACC, FRCPC -- Hamilton, Ontario, Canada
-
Robert T. Weibert, Pharm.D. -- San Diego, CA
-
Ann K Wittkowsky, PharmD, CACP, FASHP, FCCP -- Seattle, WA
Return to Editorial Board main page
|
|
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.
|